New Jersey Bariatric Center
sign in
menu
May 1, 2026
Amazon’s New GLP-1 Program: What It Covers And What Else to Consider

The difference between a transaction and a transformation matters. Short Answer:  When comparing providers, look beyond the medication. While Amazon's GLP-1 program through One Medical covers prescription access, clinical monitoring, and same-day medication delivery, ensure your choice includes dedicated nutrition counseling, support groups and muscle maintenance, as these are essential to preventing weight regain and […]

Read More
April 10, 2026
Foundayo™ (Orforglipron) FDA Approved: What NJ Patients Should Know About the New GLP-1 Pill for Weight Loss

The FDA approved Foundayo™ (orforglipron) on April 1, 2026 — a new once-daily GLP-1 weight loss pill from Eli Lilly. If you've been curious about GLP-1 medications but not looking for weekly injections, here’s what you need to know about the newest oral version. Key Takeaways What Is Foundayo™ and How Does it Work? Foundayo™ […]

Read More
March 20, 2026
Can I Start GLP‑1 Medications and Have Bariatric Surgery Later? When Does It Make Sense to Switch?

If you've started a GLP-1 medication like Wegovy® or Zepbound® and you're wondering whether bariatric surgery is still on the table — the short answer is yes. Starting with medication does not close the door to surgery. In fact, for patients at New Jersey Bariatric Center®, the path to lasting results isn't a single choice. […]

Read More
February 25, 2026
Is Pork Roll/Taylor Ham GLP-1 Friendly? A Dietitian’s Guide to NJ’s Iconic Breakfast Food

Is Pork Roll Egg and Cheese a healthy choice while on a GLP-1? While a traditional NJ breakfast sandwich is high in sodium and fat—which can trigger nausea and bloating on Wegovy® or Zepbound®—Registered Dietitian Dana recommends a high-protein, low-carb Healthy Breakfast Bake alternative to satisfy cravings without the side effects. If you've ever grabbed […]

Read More
February 17, 2026
New Wegovy® Pill vs. Wegovy® Injection: What’s the Difference?

The FDA-Approved Oral GLP-1 Wegovy® Weight Loss Pill is Now Available in New Jersey  The Wegovy® Pill for weight loss is now available throughout New Jersey after receiving FDA approval on December 22, 2025. For patients who have avoided weight loss injections due to needle-anxiety or those managing weekly injections this once-daily GLP-1 pill offers […]

Read More
January 27, 2026
No Appetite on Wegovy® or Other GLP-1s?

How to Navigate Eating Schedules, Meal Prep & Social Dining While on Weight Loss Medications and Injections By Karen Kelly, Registered Dietitian with more than 20 years of specialized experience in weight management and bariatric nutrition at New Jersey Bariatric Center® Medically Reviewed By: Alexis Begliomini, PA-C Key Takeaways GLP-1 medications eliminate the mental chatter […]

Read More
December 9, 2025
How to Combat Nausea on GLP-1 Medications (Ozempic®, Wegovy®, Zepbound®, Mounjaro®)

Nausea is a common side effect of GLP-1 weight loss medications like Ozempic®, Wegovy®, Zepbound® and Mounjaro®. It occurs due to delayed stomach emptying and the effect on appetite signals in the brain. Most nausea improves within 4-8 weeks as the body adjusts. Combat symptoms by starting with low doses, eating smaller meals, avoiding fatty […]

Read More
November 14, 2025
Are Wegovy® Pills and other Oral Weight Loss Medications Worth the Wait? What the Clinical Data Shows

Updated on December 23, 2025 to include the FDA approval of the Wegovy®pill by Novo Nordisk. With FDA-approval of the Wegovy® pill by Novo Nordisk in December 2025, the first oral versions ofGLP-1 weight loss medications are scheduled to reach the market in January 2026. Eli Lilly’s weight loss pill, Orforglipron, is still awaiting FDA-approval […]

Read More
September 17, 2025
Traveling with Weight Loss Medication like Wegovy® & Zepbound®?

By Dana Babeu, Registered Dietitian with 14 years of specialized experience in weight management and bariatric nutrition at New Jersey Bariatric Center®  Medically Reviewed by Ajay Goyal, MD, FACS Planning a vacation while taking semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), or other GLP-1 medications? You are not alone. With more than 15 million Americans now […]

Read More
September 5, 2025
Serena Williams' Weight Loss Journey Postpartum with GLP-1 Medication Zepbound®: Proof, It’s Not All About Willpower

When we learned that tennis legend Serena Williams revealed she lost 31 pounds using GLP-1 weight loss medication, Zepbound®, we immediately thought of the countless mothers in our practice who've shared the same story - doing everything 'perfectly' but still unable to lose postpartum weight. Williams specifically cited her struggles after completing breastfeeding her daughters […]

Read More
May 27, 2025
Wegovy®, Saxenda® or Qsymia®: Which Prescription Weight Loss Medication is Best for Me?

Wegovy®, Saxenda®, and Qsymia® are FDA-Approved Prescription Weight Loss Medications Available to Weight Loss Patients in New Jersey Who Qualify With so many choices how do you know which medication is best for you? Here's some points to help you decide.  Do I Qualify for Weight Loss Medications? First, determine if you meet the criteria […]

Read More
May 7, 2025
Semaglutide Compound Restrictions: FDA Ends Compound Versions of Ozempic® & Wegovy®: Here Are Available Options

FDA Declares End to Semaglutide and Tirzepatide Shortage, Restricting Compounding Production of the GLP-1s for NJ Residents Using These Medications for Weight Loss May marks a significant transition for many people on weight loss medications across New Jersey. As the FDA's April 22nd deadline for many compounding pharmacies has passed and the May 22nd deadline […]

Read More
1 2 3 5
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram